Precimmo Email Formats

Biotechnology Research • Cologne, North Rhine-Westphalia, Germany • 1-10 Employees

Key Contact at Precimmo

Shoaib Rao

Founder

Company overview

Headquarters	Cologne, North Rhine-Westphalia, Germany
NAICS	541714
Keywords	Precision Oncology, Early Cancer Detection, Multi-Omics, Advanced Biomarker Analytics, Cancer Diagnositics, Clinical Trial Recriuitment, Oncology Consultations
Founded	2023
Employees	1-10

About Precimmo

Precimmo is a precision oncology company advancing early cancer detection and AI-guided clinical decision support. Our goal is to reduce the cost of cancer care through earlier diagnosis, faster decision-making, more effective therapies, and improved patient survival by lowering relapse rates. Our platform, OncoAdvisor, integrates genomic, epigenetic, and clinical data to recommend the most appropriate diagnostics, treatments, and clinical trials, following global guidelines such as NCCN, ESMO, and ASCO. OncoAdvisor is paired with early cancer detection tools that are CE-IVD, and FDA approved, capable of detecting over 8 cancer types from a single blood test, with clinically proven accuracy of over 90%. Clinicians can input patient data and receive integrated diagnostic and therapeutic recommendations. We are committed to making cancer care more proactive, data driven, and accessible.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Precimmo has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Precimmo has never raised funding before.

Frequently asked questions

Precimmo is located in Cologne, North Rhine-Westphalia, DE.

Precimmo was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Precimmo has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Precimmo

Shoaib Rao

Founder

4.8

40,000 users